In early clinical trials, patients on GLP-1 agonists have achieved weight loss of 1520%, compared to the 510% typically seen with previous medications. Holistic approach to GLP-1 drugs Beyond weight loss, GLP-1 agonists have demonstrated the ability to reduce major cardiovascular events, combat fatty liver disease and alleviate obesity-related complications such as knee pain, sleep apnea, and acid reflux
As a consequence, the true HR would potentially be more in favor of GLP-1 RAs than the HRs observed in this study
Is retatrutide safe for long-term use
Crucially, meals that combine protein, fiber and healthy fats tend to produce the most sustained fullness, Ahn explained
Kidney function Periodic blood tests to monitor kidney health
Patients in Stamford, Greenwich, Fairfield County, and throughout Connecticut can call 203-348-8805 to discuss whether medical weight loss, GLP-1 therapy, semaglutide, tirzepatide, or another physician-supervised option may be appropriate